Year: 2021

Providing tax and reporting requirements for transportation companies in Mexico NEW YORK, Dec. 08, 2021 (GLOBE NEWSWIRE) — Hudson Capital Inc. (NASDAQ: HUSN) (Hudson Capital) announced that Freight App, Inc. (Fr8App), a North American transportation logistics technology platform company focused on US-Mexico cross-border shipping with which Hudson Capital has signed a merger agreement, has launched a new offering to address tax and reporting requirements related to Carta Porte for transportation companies in Mexico. Javier Selgas, CEO of Fr8App, said, “As a leader in the transportation technology, Fr8App delivers solutions that improve the efficiency and profitability of our carrier and shipper partners. This new reporting offering is particularly helpful to carriers since 80% of them are owner-operators who do not have dedicated...

VANCOUVER, British Columbia, Dec. 08, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (“cGMP”) of AP-188 (“N,N-Dimethyltryptamine or DMT”) at Canadian manufacturer Dalton Pharma Services. The Company believes it has produced a sufficient supply of cGMP DMT to complete its planned Phase 1 and Phase 2 clinical trials. The Company also announces it has appointed Dr. Anthony Rudd and Dr. Robert Simister, both from the U.K., as medical consultants to the Company’s DMT stroke clinical research program. Both Dr. Rudd and Dr. Simister have extensive backgrounds in stroke management as well as clinical care and stroke...

ATLANTA, Dec. 08, 2021 (GLOBE NEWSWIRE) — Chart Industries, Inc. (“Chart” or the “Company”) (NYSE: GTLS) and Howden have signed a Memorandum of Understanding (MOU) as they move forward in collaboration for advanced hydrogen solutions, incorporating Howden gas compression systems into Chart hydrogen offerings. Howden is a leading global provider of mission critical air and gas handling products, technologies and services across a diverse range of industries, while Chart is a leading global manufacturer of highly engineered equipment, servicing multiple applications in the clean energy and industrial gas markets. This relationship will result in more cost-effective standardised solutions within an integrated and optimised service offering. This will provide customers with tailored global aftermarket support and will leverage both...

ATLANTA, Dec. 08, 2021 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that the Descartes MacroPoint™ Capacity Network of over 280,000 carriers is directly accessible from the McLeod Software PowerBroker® transportation management system (TMS) to help freight brokers and third party logistics (3PL) providers source capacity and cover more loads. The Descartes MacroPoint Capacity Network allows brokers to access over 280,000 carriers and their assets on more than 1 million truckload transportation lanes in North America. By using machine learning to match potential carriers in near real-time to open loads, the solution helps brokers to better rank carrier matches. Brokers can send load offers to carriers either manually or automatically...

LAS VEGAS, NV, Dec. 08, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — GZ6G Technologies Corp. (OTCQB: GZIC) today announced an expanded offering for clients focused on cybersecurity leadership initiatives designed to protect smart city and smart venue network infrastructures and future IoT technologies from cyber breaches through enhanced services provided by in house networks division, Green Zebra Networks. “We’re initiating enhanced cybersecurity solutions as part of our value proposition to protect against the new wave of attacks coming in from sensors and other smart systems, such as ventilation or surveillance. We will continue to strengthen cybersecurity applications as we grow and develop new alliances,” said Coleman Smith, CEO of GZ6G. “Our Networks team of engineers constantly monitor and test for vulnerabilities. Cyber...

HEIDELBERG, Germany, Dec. 08, 2021 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today the initiation of patient recruitment for the open-label, multi-center phase 1/2a study evaluating the safety, tolerability, pharmacokinetics and efficacy of the innate cell engager (ICE®) AFM24 in combination with Roche’s atezolizumab, an anti-PD-L1 checkpoint inhibitor. AFM24 is Affimed’s tetravalent, bispecific epidermal growth factor receptor (EGFR)- and CD16A-targeting ICE®, developed for the treatment of patients with solid tumors. “Natural killer cells, which are part of the innate immune system, have the ability to recognise cancer cells. AFM24, a novel immunotherapy, aims to redirect and engage these natural killer...